209 related articles for article (PubMed ID: 16586433)
21. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.
Schwegler EE; Cazares L; Steel LF; Adam BL; Johnson DA; Semmes OJ; Block TM; Marrero JA; Drake RR
Hepatology; 2005 Mar; 41(3):634-42. PubMed ID: 15726646
[TBL] [Abstract][Full Text] [Related]
22. Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGE.
Ferrín G; Ranchal I; Llamoza C; Rodríguez-Perálvarez ML; Romero-Ruiz A; Aguilar-Melero P; López-Cillero P; Briceño J; Muntané J; Montero-Álvarez JL; De la Mata M
Liver Int; 2014 Mar; 34(3):438-46. PubMed ID: 23944848
[TBL] [Abstract][Full Text] [Related]
23. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
24. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
[TBL] [Abstract][Full Text] [Related]
25. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
26. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
27. Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system.
Kanmura S; Uto H; Kusumoto K; Ishida Y; Hasuike S; Nagata K; Hayashi K; Ido A; Stuver SO; Tsubouchi H
Hepatology; 2007 Apr; 45(4):948-56. PubMed ID: 17393466
[TBL] [Abstract][Full Text] [Related]
28. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
29. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera.
Chignard N; Shang S; Wang H; Marrero J; Bréchot C; Hanash S; Beretta L
Gastroenterology; 2006 Jun; 130(7):2010-22. PubMed ID: 16762624
[TBL] [Abstract][Full Text] [Related]
30. Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry coupled with an artificial neural network model for the diagnosis of hepatocellular carcinoma.
Hu Q; Huang Y; Wang Z; Tao H; Liu J; Yan L; Wang K
Hepatogastroenterology; 2012 Sep; 59(118):1902-6. PubMed ID: 22193438
[TBL] [Abstract][Full Text] [Related]
31. 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis.
Zubaidah RM; Tan GS; Tan SB; Lim SG; Lin Q; Chung MC
Proteomics; 2008 Dec; 8(23-24):5086-96. PubMed ID: 19003864
[TBL] [Abstract][Full Text] [Related]
32. [Study of serum proteome biomarkers with relation to the formation of portal vein tumor thrombi in hepatocellular carcinoma patients].
Huang C; Fan J; Zhou J; Liu YK; Cui JF; Kang XN; Yang PY; Tang ZY
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):781-5. PubMed ID: 15949388
[TBL] [Abstract][Full Text] [Related]
33. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.
Göbel T; Vorderwülbecke S; Hauck K; Fey H; Häussinger D; Erhardt A
World J Gastroenterol; 2006 Dec; 12(47):7604-12. PubMed ID: 17171788
[TBL] [Abstract][Full Text] [Related]
34. [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients].
Huang C; Fan J; Zhou J; Liu YK; Cui JF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):445-9. PubMed ID: 16772076
[TBL] [Abstract][Full Text] [Related]
35. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
Gourin CG; Zhi W; Adam BL
Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
[TBL] [Abstract][Full Text] [Related]
36. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
37. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
38. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
[TBL] [Abstract][Full Text] [Related]
39. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
40. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
Mustafa MG; Petersen JR; Ju H; Cicalese L; Snyder N; Haidacher SJ; Denner L; Elferink C
Mol Cell Proteomics; 2013 Dec; 12(12):3640-52. PubMed ID: 24008390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
